Anat Loewenstein

Tel Aviv University — Israel

Medicine · Health Sciences

33h-index4.2kcitations217works3.42yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Retinal Diseases and Treatments(115), Retinal Imaging and Analysis(57), Retinal and Optic Conditions(56), Glaucoma and retinal disorders(53), Retinal and Macular Surgery(34)

Publications215 total

Home Monitoring for the Management of Age-Related Macular Degeneration: A Review of the Development and Implementation of Digital Health Solutions over a 25-Year Scientific Journey
Medicina·2025Open Access
FYB-201 Biosimilar ranibizumab (Ongavia/Ranivisio/Cimerli) Efficacy and Safety in Clinical Settings – FORCE study
Eye·2025· 2 cited
Inclusive and accessible implementation of telemedicine: Insights from the United Nations international expert roundtable
Health Informatics Journal·2025Open Access
Pegcetacoplan Treatment for Geographic Atrophy in Age-Related Macular Degeneration Over 36 Months: Data From OAKS, DERBY, and GALE
American Journal of Ophthalmology·2025· 6 citedOpen Access
Biosimilar Ranibizumab (Ranieyes) Safety and Efficacy in the Real World: BRESER Study
Journal of VitreoRetinal Diseases·2025· 5 citedOpen Access
Aflibercept 2 mg biosimilars—will they lead the Anti-VEGF biosimilar world globally
Eye·2025· 5 cited
"Choosing wisely": Intravitreal gas injection as first-line treatment for macular hole-a clinical case perspective.
Retinal Cases & Brief Reports·2025Open Access
Refractive Lens Exchange and Choroidal Neovascularization
2025
Global Insights from Patients, Providers, and Staff on Challenges and Solutions in Managing Neovascular Age-Related Macular Degeneration
Ophthalmology and Therapy·2024· 4 citedOpen Access
Improving Clinical Management of Diabetic Macular Edema: Insights from a Global Survey of Patients, Healthcare Providers, and Clinic Staff
Ophthalmology and Therapy·2024· 6 citedOpen Access
Choroidal Response to Intravitreal Bevacizumab Injections in Treatment-Naïve Macular Neovascularization Secondary to Chronic Central Serous Chorioretinopathy
Biomedicines·2024· 1 citedOpen Access
Punctate hyperreflective vitreous opacities: a ubiquitous finding in healthy children beyond infancy
Eye·2024· 1 citedOpen Access
Choroidal Response to Intravitreal Bevacizumab Injections in Treatment-Naïve Macular Neovascularization Secondary to Chronic Central Serous Chorioretinopathy
Preprints.org·2024Open Access
Reply
Retina·2024
Treatment regimens for optimising outcomes in patients with neovascular age-related macular degeneration
Eye·2024· 7 citedOpen Access
The digital age in retinal practice
International Journal of Retina and Vitreous·2024· 2 citedOpen Access
Anti-VEGF Biosimilars for Retinal Diseases Survey 2023- India (Bio-INDAS) by the International Retina Biosimilar Study Group (Inter-BIOS Group) in collaboration with the Vitreo-Retinal Society of India (VRSI)
Eye·2024· 11 citedOpen Access
Subfoveal neurosensory detachment flattening and observe (SNF-Ob) approach for the management of Ci-DMO - a multicentric study
Eye·2024Open Access
United Nations Roundtable on Telemedicine: Lessons Learned and Differing Perspectives (Preprint)
2024Open Access
C5 inhibitor avacincaptad pegol treatment for geographic atrophy: A comprehensive review
Immunotherapy·2024· 17 citedOpen Access
page 1 of 11Next →

Frequent Co-authors

Dinah Zur(18), Matías Iglicki(15), Jay Chhablani(11), Francesco Bandello(11), Adiel Barak(10), Ashish Sharma(10), Baruch D. Kuppermann(10), Catharina Busch(9), Nilesh Kumar(9), Marco Lupidi(8), Zafer Cebeci(7), Samantha Fraser‐Bell(7), Voraporn Chaikitmongkol(6), Ermete Giancipoli(5), Matúš Rehák(5), Mali Okada(5), Nikulaa Parachuri(5), Aude Couturier(4), Inês Laíns(4), Anna Sala‐Puigdollers(4)